Profile photo Marjolein Hensgens

Marjolein Hensgens

Assistant Professor - medical

Strategic program(s):

Research groups

Epidemiology and clinical trials in infectious diseases

Research aim

To improve prevention, diagnosis and treatment of infectious diseases and to establish an international research infrastructure for a rapid scientific response in the face of a new infectious disease threat.

Go to group

Transplantation

Research aim

We aim to understand how infection and immunity impact transplantation. By uncovering these mechanisms, we aim to improve patient care, reduce rejection and complications, and enhance success rates, benefiting society with better health outcomes.

Go to group

Recent publications

Cefazoline wordt eerste keus bij S. aureus-bacteriëmie Nynke G.L. Jager, Marjolein P.M. Hensgens
Nederlands Tijdschrift voor Geneeskunde, 2026, vol. 170
Acute kidney injury in Staphylococcus aureus bacteraemia F S Sinkeler, I J E Kouijzer, N G L Jager, J Ten Oever, E Leegwater, J Gisolf, D Reuling, Z M Spoel, M P M Hensgens, R J Brüggemann
The Journal of antimicrobial chemotherapy, 2026, vol. 81
Randomized Clinical Trials Using a Hierarchical Composite Primary End Point Selina Ehrenzeller, Amos J de Jong, Yonas Martin, Marlieke E A de Kraker, Holly Jackson, Nasreen Hassoun-Kheir, Michaela Schumacher, Nadine Saskia Bernasconi, Marjolein P M Hensgens, Christian Appenzeller-Herzog, Natalie Rose, Steven Y C Tong, Nina Khanna, Richard Kuehl, Matthias Briel, Sean W X Ong, Benjamin Speich
JAMA network open, 2026, vol. 9
A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa Anna L Goodman, Nicholas Easom, Dana Bielopolski, Rebecca K Sutherland, Michael Marks, Marjolein P M Hensgens, Marc Bonten, Jennifer Bostock, Genevieve Walls, David Lye, Tom Boyles, Dafna Yahav, Matthew P Cheng, Amy Legg, Mical Paul, François-Xavier Lescure, Todd C Lee, Steven Y C Tong, Joshua S Davis
The Journal of antimicrobial chemotherapy, 2026, vol. 81
Considerations raised during the regulatory and ethics review of platform clinical trials in infectious diseases Amos de Jong, Denise van Hout, Janneke Verberk, Marjolein Hensgens, Alike van der Velden, Janneke H. van de Wijgert, Marc Bonten, LP Derde
Contemporary clinical trials communications, 2026, vol. 51